tiprankstipranks
Swedish Orphan Biovitrum AB (SE:SOBI)
:SOBI
Sweden Market
SOBI
Swedish Orphan Biovitrum AB
RESEARCH TOOLSreports
Want to see SE:SOBI full AI Analyst Report?

Swedish Orphan Biovitrum AB (SOBI) Stock Forecast & Price Target

6 Followers
See the Price Targets and Ratings of:

SOBI Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Swedish
Orphan Biovitrum AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SOBI Stock 12 Month Forecast

Average Price Target

kr495.00
▲(27.38% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Swedish Orphan Biovitrum AB in the last 3 months. The average price target is kr495.00 with a high forecast of kr550.00 and a low forecast of kr350.00. The average price target represents a 27.38% change from the last price of kr388.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"263":"kr263","335":"kr335","407":"kr407","479":"kr479","551":"kr551"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":550,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr550.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":495,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr495.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":350,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr350.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[263,335,407,479,551],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,468.2,474.4923076923077,480.7846153846154,487.0769230769231,493.36923076923074,499.66153846153844,505.95384615384614,512.2461538461538,518.5384615384615,524.8307692307692,531.123076923077,537.4153846153846,543.7076923076922,{"y":550,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,468.2,470.26153846153846,472.32307692307694,474.38461538461536,476.44615384615383,478.5076923076923,480.5692307692308,482.6307692307692,484.6923076923077,486.75384615384615,488.81538461538463,490.87692307692305,492.9384615384615,{"y":495,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,468.2,459.1076923076923,450.0153846153846,440.9230769230769,431.8307692307692,422.73846153846154,413.6461538461538,404.55384615384617,395.46153846153845,386.36923076923074,377.2769230769231,368.18461538461537,359.0923076923077,{"y":350,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":285.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":332.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":345.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":407.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":427.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":434.2,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":468.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Targetkr550.00Average Price Targetkr495.00Lowest Price Targetkr350.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on SE:SOBI
James Gordon CFA
Barclays
Barclays
kr470→kr530
Buy
36.39%
Upside
Reiterated
07/03/26
Swedish Orphan price target raised to SEK 530 from SEK 470 at BarclaysSwedish Orphan price target raised to SEK 530 from SEK 470 at Barclays
H.C. Wainwright Analyst forecast on SE:SOBI
Mitchell Kapoor
H.C. Wainwright
H.C. Wainwright
kr550
Buy
41.53%
Upside
Reiterated
06/29/26
Buy Rating Reiterated on Sobi as NASP Delay Seen as Timing Issue; SEK 550 Price Target Maintained
Berenberg Bank Analyst forecast on SE:SOBI
Harry Gillis
Berenberg Bank
Berenberg Bank
kr525→kr550
Buy
41.53%
Upside
Reiterated
06/23/26
Berenberg Bank Keeps Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)
Kepler Capital Analyst forecast on SE:SOBI
Jon Berggren
Kepler Capital
Kepler Capital
kr350
Buy
-9.93%
Downside
Reiterated
04/29/26
Kepler Capital Reaffirms Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)
Exane BNP Paribas Analyst forecast on SE:SOBI
Kirsty Ross Stewart
Exane BNP Paribas
Exane BNP Paribas
kr475
Buy
22.23%
Upside
Upgraded
02/10/26
Swedish Orphan upgraded to Outperform from Underperform at BNP ParibasSwedish Orphan upgraded to Outperform from Underperform at BNP Paribas
RBC Capital Analyst forecast on SE:SOBI
Alistair Campbell
RBC Capital
RBC Capital
kr345→kr350
Buy
-9.93%
Downside
Reiterated
07/22/25
RBC Capital Sticks to Its Buy Rating for Swedish Orphan Biovitrum AB (0MTD)
Deutsche Bank Analyst forecast on SE:SOBI
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
kr285
Hold
-26.66%
Downside
Upgraded
07/08/25
Swedish Orphan Biovitrum AB (0MTD) was upgraded to a Hold Rating at Deutsche Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on SE:SOBI
James Gordon CFA
Barclays
Barclays
kr470→kr530
Buy
36.39%
Upside
Reiterated
07/03/26
Swedish Orphan price target raised to SEK 530 from SEK 470 at BarclaysSwedish Orphan price target raised to SEK 530 from SEK 470 at Barclays
H.C. Wainwright Analyst forecast on SE:SOBI
Mitchell Kapoor
H.C. Wainwright
H.C. Wainwright
kr550
Buy
41.53%
Upside
Reiterated
06/29/26
Buy Rating Reiterated on Sobi as NASP Delay Seen as Timing Issue; SEK 550 Price Target Maintained
Berenberg Bank Analyst forecast on SE:SOBI
Harry Gillis
Berenberg Bank
Berenberg Bank
kr525→kr550
Buy
41.53%
Upside
Reiterated
06/23/26
Berenberg Bank Keeps Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)
Kepler Capital Analyst forecast on SE:SOBI
Jon Berggren
Kepler Capital
Kepler Capital
kr350
Buy
-9.93%
Downside
Reiterated
04/29/26
Kepler Capital Reaffirms Their Buy Rating on Swedish Orphan Biovitrum AB (0MTD)
Exane BNP Paribas Analyst forecast on SE:SOBI
Kirsty Ross Stewart
Exane BNP Paribas
Exane BNP Paribas
kr475
Buy
22.23%
Upside
Upgraded
02/10/26
Swedish Orphan upgraded to Outperform from Underperform at BNP ParibasSwedish Orphan upgraded to Outperform from Underperform at BNP Paribas
RBC Capital Analyst forecast on SE:SOBI
Alistair Campbell
RBC Capital
RBC Capital
kr345→kr350
Buy
-9.93%
Downside
Reiterated
07/22/25
RBC Capital Sticks to Its Buy Rating for Swedish Orphan Biovitrum AB (0MTD)
Deutsche Bank Analyst forecast on SE:SOBI
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
kr285
Hold
-26.66%
Downside
Upgraded
07/08/25
Swedish Orphan Biovitrum AB (0MTD) was upgraded to a Hold Rating at Deutsche Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Swedish Orphan Biovitrum AB

3 Months
Harry GillisBerenberg Bank
Success Rate
11/15 ratings generated profit
73%
Average Return
+6.81%
Copying Harry Gillis's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +6.81% per trade.
1 Year
Harry GillisBerenberg Bank
Success Rate
14/15 ratings generated profit
93%
Average Return
+21.63%
Copying Harry Gillis's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +21.63% per trade.
2 Years
Harry GillisBerenberg Bank
Success Rate
15/15 ratings generated profit
100%
Average Return
+40.77%
Copying Harry Gillis's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +40.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SOBI Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
5
7
7
9
7
Hold
1
1
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
8
7
10
8
In the current month, SOBI has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SOBI average Analyst price target in the past 3 months is 495.00.
Each month's total comprises the sum of three months' worth of ratings.

SOBI Financial Forecast

SOBI Earnings Forecast

Next quarter’s earnings estimate for SOBI is kr3.35 with a range of kr3.03 to kr3.59. The previous quarter’s EPS was kr3.81. SOBI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SOBI has Performed in-line its overall industry.
Next quarter’s earnings estimate for SOBI is kr3.35 with a range of kr3.03 to kr3.59. The previous quarter’s EPS was kr3.81. SOBI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SOBI has Performed in-line its overall industry.

SOBI Sales Forecast

Next quarter’s sales forecast for SOBI is kr7.32B with a range of kr7.14B to kr7.51B. The previous quarter’s sales results were kr7.18B. SOBI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SOBI has Performed in-line its overall industry.
Next quarter’s sales forecast for SOBI is kr7.32B with a range of kr7.14B to kr7.51B. The previous quarter’s sales results were kr7.18B. SOBI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SOBI has Performed in-line its overall industry.

SOBI Stock Forecast FAQ

What is SE:SOBI’s average 12-month price target, according to analysts?
Based on analyst ratings, Swedish Orphan Biovitrum AB’s 12-month average price target is 495.00.
    What is SE:SOBI’s upside potential, based on the analysts’ average price target?
    Swedish Orphan Biovitrum AB has 27.38% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Swedish Orphan Biovitrum AB a Buy, Sell or Hold?
          Swedish Orphan Biovitrum AB has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Swedish Orphan Biovitrum AB’s share price target?
            The average share price target for Swedish Orphan Biovitrum AB is 495.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr550.00 ,and the lowest forecast is kr350.00. The average share price target represents 27.38% Increase from the current price of kr388.6.
              What do analysts say about Swedish Orphan Biovitrum AB?
              Swedish Orphan Biovitrum AB’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Swedish Orphan Biovitrum AB?
                To buy shares of SE:SOBI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.